Advanced search
Publication Cover
Current Medical Research and Opinion Volume 7, 1982 - Issue 10
Submit an article Journal homepage
5
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Low dose guanfacine once-a-day for the treatment of hypertension in general practice: A multi-centre pilot study

K. Westelinck Clinical Research, Sandoz Brussels, Brussels, Belgium
&
Y. Michotte Centrum voor Biomathematika, Vrije Universiteit Brussel, Brussels, Belgium
Pages 631-638 | Received 03 Nov 1981, Published online: 11 Aug 2008

References

  • Arnold O. H. Die medikamentöse Therapie der arteriellen Hypertonic. Intern. Praxis 1971; 11: 451–4551. Arnold O. H. Die medikamentöse Therapie der arteriellen Hypertonic. Intern. Praxis 1971; 11: 451–455
  • Dollery C. T., Davis D. S. Centrally acting drugs in antihypertensive therapy. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)5S–12S2. Dollery C. T., Davis D. S. Centrally acting drugs in antihypertensive therapy. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)5S–12S
  • Friedberg C. K. Diseases of the Heart, 3rd Edit. Saunders, Philadelphia, London 1967; 673. Friedberg C. K. Diseases of the Heart3rd Edit. Saunders, Philadelphia, London 1967; 67
  • Jerie P. Clinical experience with guanfacine in longterm treatment of hypertension. Part I: efficacy and dosage. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)37S–47S4. Jerie P. Clinical experience with guanfacine in longterm treatment of hypertension. Part I: efficacy and dosage. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)37S–47S
  • Jerie P. Clinical experience with guanfacine in longterm treatment of hypertension. Part II: adverse reactions to guanfacine. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)157S–164S5. Jerie P. Clinical experience with guanfacine in longterm treatment of hypertension. Part II: adverse reactions to guanfacine. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)157S–164S
  • Jerie P., Lasance A. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy. Int. J. Clin. Pharmacol. Ther. Toxicol. 1981; 19: 279–2876. Jerie P., Lasance A. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy. Int. J. Clin. Pharmacol. Ther. Toxicol. 1981; 19: 279–287
  • Kiechel J. R. Pharmacokinetics and metabolism of guanfacine in man: a review. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)25S–32S7. Kiechel J. R. Pharmacokinetics and metabolism of guanfacine in man: a review. Br. J. Clin. Pharmacol. 1980; 10(Suppl. 1)25S–32S
  • Meier J., Beveridge T., Laplanche R., Kiechel J. R., Ohnhaus E. E. (1978) Pharmacokinetics of the hypotensive agent guanfacine in man. Communication VIIIth Congress of Cardiology, Tokyo, 19788. Meier J., Beveridge T., Laplanche R., Kiechel J. R., Ohnhaus E. E. (1978) Pharmacokinetics of the hypotensive agent guanfacine in man. Communication VIIIth Congress of Cardiology, Tokyo, 1978
  • Rengo F., Ricciardelli B., Volpe M., Trimarco B., Sasca L., Condorelli M. Long term comparative study of guanfacine and alpha‐methyl‐dopa in essential hypertension. Arch. Int. Pharmacodyn. Ther. 1980; 244: 281–2919. Rengo F., Ricciardelli B., Volpe M., Trimarco B., Sasca L., Condorelli M. Long term comparative study of guanfacine and alpha‐methyl‐dopa in essential hypertension. Arch. Int. Pharmacodyn. Ther. 1980; 244: 281–291
  • Saameli K., Scholtyzik G., Waite R. Pharmacology of BS‐100/141, a centrally acting antihypertensive drug. Clin. Exp. Pharmacol. Physiol. 1975; 2: 20710. Saameli K., Scholtyzik G., Waite R. Pharmacology of BS‐100/141, a centrally acting antihypertensive drug. Clin. Exp. Pharmacol. Physiol. 1975; 2: 207
  • Westelinck K., Defrise‐Gussenhoven E., Michotte Y. Statistical analysis — Estulic (BS 100–141) 2 mg tablets — hypertension. Sandoz, Brussels 1980, Unpublished data on file11. Westelinck K., Defrise‐Gussenhoven E., Michotte Y. Statistical analysis — Estulic (BS 100–141) 2 mg tablets — hypertension. Sandoz, Brussels 1980, Unpublished data on file

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.